Lieky ATC skupiny B02BD04
Awarded
The competition has ended and a winner has been selected.
- Award
- Procedure
- OpenSingle stage
Brief
Všeobecná zdravotná poisťovňa, a.s. uzavrela rámcovú dohodu so spoločnosťou ViaPharma SK s. r. o. na dodávku liekov ATC skupiny B02BD04 (Koagulačný faktor IX, parent rFIXFc (eftrenonakog alfa)) na obdobie 36 mesiacov s maximálnou celkovou hodnotou 9 094 943 EUR. Kritériom pre udelenie zákazky bola najnižšia cena a bola prijatá jedna ponuka.
Medisinsk engroshandel
Result
- ViaPharma SK s. r. o.Winner
- 1Number of tenders received
- Not statedContract value
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Všeobecná zdravotná poisťovňa, a.s.
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Najnižšia cena
Source
No source found in the documents. Check the weight against the tender documents.
From the notice
Lieky ATC skupiny B02BD04, Koagulačný faktor IX, parent rFIXFc (eftrenonakog alfa)
Contact
jana.hosova@vszp.sk- Result · Framework agreementType
- 33621000Main codeMedicinal products for the blood and blood-forming organs